As a Harvard and NYU-educated, board-certified plastic surgeon, Dr. Rapaport has a track record of over 24 years of achieving exquisite results for his clients, and is dedicated to providing the most innovative and groundbreaking new treatments on the market. He is joined by Dr. Darren Smith, another experienced surgeon in body contouring and other minimally/non-invasive treatments. At Coolspa, each patient receives a customized, one-on-one consultation and treatment that targets their unique trouble zones. This personalized attention coupled with expert skill and artistry is the reason why Coolspa is known as NYC’s premier body sculpting center.
One of the main hurdles in getting to the end point from the start is a patient’s determination to follow all the instructions given by their respective doctors. While the treatment sessions involve little to no effort on the patient’s part, the rest of the recovery procedure solely depends on the patient. The best thing to do is follow a regular diet and adhere to it no matter what. Same goes for the exercise regimen. Body sculpting treatments without surgery is a painless and non-invasive procedure that shows promise. If a patient is able to avail this technology to get into better shape without the hassle and pain of surgery, then it is recommended to try a non-invasive treatment.
"I would like to say it is ready to replace liposuction, but it's not -- yet," he says. Still it does have certain benefits over liposuction namely that a person can have the treatment and go to lunch afterward, Fodor says. Unlike liposuction, the new technology does not involve pain, scars, anesthesia, or a long recovery time. Only some topical anesthesia is used, he says.

Fodor is more enthusiastic about the LipoSonix technology. "I am very optimistic," he says." I love the results," he says citing as much as a 7-centimeter reduction in waist circumference seen in clinical trials conducted in Mexico. This technology, which uses high-intensity ultrasound waves, beamed about an inch under the skin to break up fatty tissue, has been studied in both pig models and in 33 people in Mexico, he says. The company has applied for FDA status to begin preclinical studies in the U.S. and expects such trials to begin in 2007.

1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.

×